Live feed
Filing
SC 13D/A
SC 13D/A0001193125-24-247656·Monte Rosa Therapeutics, Inc.
Schedule 13D ownership disclosure
Monte Rosa Therapeutics Inc
Security class unavailable · CUSIP: 61225M102
Event date: 2024-10-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-247656
- Form type
- SC 13D/A
- Filer
- Monte Rosa Therapeutics, Inc.
- CIK
- CIK 1826457
- Filed
- Oct 30, 2024
- Reporting period
- Oct 28, 2024
- Description
- Schedule 13D beneficial ownership